New York maps coronavirus genome to help track future outbreaks
By Hussein Waaile and Jonathan Allen NEW YORK (Reuters) - Scientists at New York City's health department have begun to analyze the novel coronavirus's genetic material to allow them to trace the origins of any future outbreaks in the coming months as they cautiously look to reopen the largely shuttered city. Their work joins similar efforts at scores of institutions around the world, which have been sequencing the genomes of virus samples and pooling their findings in an online global database, allowing researchers to observe subtle differences between samples to track the outbreak's spread. Dr
coronavirus genome to help track future outbreaks" src="https://images.firstpost.com/wp-content/themes/firstpost/images/220x220_Watermark.jpg" alt="New York maps coronavirus genome to help track future outbreaks" width="300" height="225" />
By Hussein Waaile and Jonathan Allen
NEW YORK (Reuters) - Scientists at New York City's health department have begun to analyze the novel coronavirus 's genetic material to allow them to trace the origins of any future outbreaks in the coming months as they cautiously look to reopen the largely shuttered city.
Their work joins similar efforts at scores of institutions around the world, which have been sequencing the genomes of virus samples and pooling their findings in an online global database, allowing researchers to observe subtle differences between samples to track the outbreak's spread.
Dr. Oxiris Barbot, the city's health commissioner, told Reuters during a tour this week of the Public Health Laboratory in Manhattan that genome sequencing could help blunt any second wave of infections later in the year.
"We can use that fingerprint information to understand if those additional infections are due to infections that were still here in the city or if they've been imported from someplace else," she said in an interview, wearing a floral-patterned cloth mask over her nose and mouth.
On the laboratory's ninth floor, scientists in blue protective gear and face shields are working on the sequencing in cramped rooms, the doors to which are plastered with hazard warnings and rules on safety precautions.
Colleagues on other floors run diagnostic tests for COVID-19 , the potentially lethal respiratory illness caused by the coronavirus , on samples sent over from city hospitals without their own testing facilities.
Showerheads are embedded in the ceilings of the building's drab corridors, and can be activated with the yank of a cord if a worker fears they have been contaminated by whatever they are studying.
The genome of the novel coronavirus consists of a single, short strand of ribonucleic acid, or RNA, a distinctive sequence of genetic base molecules, sometimes described by letters, that the virus uses to hijack its host's cellular machinery and make copies of itself.
Only four different kinds of letters make up a string of RNA, referred to by geneticists as c, u, a and g. The novel coronavirus genome is about 30,000 letters long, tiny compared with the 3 billion letters that make up the DNA, or deoxyribonucleic acid, of the human genome.
As the virus replicates itself inside its host, it can make tiny transcription errors, altering its genetic signature. These mutations, which can be passed along in subsequent infections, can be detected in samples taken from patients to create a sort of genetic family tree.
Across First Avenue from the Public Health Laboratory, scientists at New York University's Grossman School of Medicine who sequenced samples of the virus deduced that the variant of the virus dominating in New York City - the heart of one the deadliest outbreaks in the world - arrived via Europe.
"It's sort of like doing detective work," Adriana Heguy, one of the New York University researchers, said in an interview.
She has been sharing her results with colleagues around the world via the Germany-based GISAID database, which was created to track the ebb and flow of influenza viruses. "You can find your chain of transmission by doing this," she said.
Health officials can use this knowledge to determine which measures are more effective than others and where their points of vulnerability may lie.
While most mutations are trivial and do not affect the virus's behavior, Heguy and other researchers are also working to amass enough samples to see if there are any clinical differences seen in different variants of the virus, and their work may help design a vaccine that offers the broadest possible protection.
(Reporting by Jonathan Allen and Hussein Waaile, editing by Ross Colvin and Jonathan Oatis)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Stephen Nellis (Reuters) -Apple Inc on Monday said it will offer the ability to store state-issued identification cards digitally on iPhones and that it is working with the U.S. Transportation Security Administration to accept the digital IDs at airports, one of several updates to the software that runs on its devices. It also showed updates to its FaceTime video chat app, adding the ability to schedule calls with multiple attendees and making the software compatible with Android and Windows devices.
LONDON (Reuters) - The bosses of all airlines flying passenger services between Britain and the United States called on Monday for the countries' governments to relax COVID-19 restrictions to reopen travel routes between the two countries. After more than a year of restrictions, the CEOs of American Airlines, IAG unit British Airways, Delta Air Lines, United Airlines and JetBlue Airways Corp said high vaccination rates in both countries meant travel could restart safely. The push for reopening trans-Atlantic routes on Monday comes ahead of meetings between U.S.
BRUSSELS (Reuters) - The European Union's patience towards Britain over Brexit arrangements in Northern Ireland is wearing thin and the bloc will consider its options should Britain continue its "confrontational path", an EU official said on Monday.